News
Entertainment
Science & Technology
Sport
Business & Money
Life
Culture & Art
Hobbies
9 | Follower
CNBC Investing
21.11.2024
Shares have already surged more than 56% in 2024.
One of the most anticipated earnings releases of the quarter could spark big moves.
There are only a few weeks left in the year, and some stocks may still be due for gains, according to Oppenheimer.
The firm initiated coverage of the energy company with an overweight rating.
Corporate insiders are taking advantage of the stock market's postelection boom to all-time highs, unloading shares at record levels.
The Wall Street firm thinks that stocks tend to experience a technical pull higher when active ownership is much lower than their weightings in the S&P 500.
Tony Zhang updates the winning trade he made in September.
President-elect Donald Trump's second term could spell big gains for this stock, according to Bernstein.
Here are Wednesday's biggest calls on Wall Street.
Uranium prices are expected to remain elevated as demand outstrips supply.
Frank Cappelleri breaks down the charts in Albemarle.
The major averages ended Wednesday's session mixed, with the S&P 500 closing near the flatline. Here's what CNBC is watching going into Thursday.
Analysts expect the chipmaker to post earnings of 75 cents per share on about $33.16 billion in revenue, or more than 80% revenue growth compared to a year ago.
20.11.2024
Baron Capital, known for being an early and big investor in Tesla, actually has a sizable exposure to small caps, especially those with a growth tilt.
Todd Gordon breaks down the charts on Nvidia and gives a hedging strategy into earnings.
Analyst Joshua Chan upgraded shares to buy from neutral.
The S&P 500 and the Nasdaq Composite ended Tuesday higher, as shares of Nvidia lifted the indexes. Here's what's on CNBC's radar going into Wednesday.
The U.S. stock market has been having a party for most of November but hasn't invited the rest of the world to join the fun.
The record-breaking numbers for the match between Mike Tyson and Jake Paul show Netflix's preeminence in the streaming sector, per Pivotal Research.
Some stocks could benefit from an RFK Jr.-helmed Department of Health and Human Services, according to Bank of America and Wells Fargo.
The firm initiated coverage with an overweight rating and $400 price target on shares, implying shares could climb an additional 24.5% from Tuesday's close.
The firm said defense valuations are already high and forecasts the U.S. defense budget will soon flatten out and then decline.
These stocks offer investors a steady stream of income and could rise under a second Trump term.
Here are the biggest calls on Wall Street on Tuesday.
Now may be the time for investors to buy shares of BioNTech, according to Evercore ISI.
Morgan Stanley's trading desk found stocks that are closely tied to government spending.
Nishant Pant describes a trade set-up in the SPDR Gold Shares.
19.11.2024
This pharmaceutical company's recent drug developments could spell more gains ahead, according to Jefferies.
This financial services platform is slated for more gains under a second Trump term, according to Needham.
Frank Holland breaks down what traders are watching ahead of the new session.
Even as the investment bank expects a 'return to normalcy' year, its forecast still calls for strong gains for the broad market index.
A look at the failing charts of Applied Materials and Lam Research.
Here are Monday's biggest calls on Wall Street.
Mike Khouw breaks down a trade in BJ's Wholesale Club.
Investors may like AT&T for its juicy dividend, but it also has "significant upside" ahead, according to Goldman Sachs.
Elon Musk's role within Donald Trump's inner circle reinforces the "tough to bet against him thesis," according to Barclays.
18.11.2024
Roku's huge underperformance this year has created an attractive buying opportunity for investors, according to Baird.
Here are Evercore ISI's favorite tech stocks to own heading into 2025.
Accelerating earnings growth should drive shares of Futu Holdings higher, according to Morgan Stanley.
Chinese stocks face mounting challenges as earnings have yet to pick up, while U.S. trade tensions loom.